PREVALENCE AND PREVENTIVE MEASURES OF CONJUNCTIVITIS IN PATIENTS WITH CORONAVIRUS INFECTION (COVID-19)

Abstract

According to the American Academy of Ophthalmology, the spread of the coronavirus infection can cause viral follicular conjunctivitis. However, the pathways and tropism in conjunctival cells are still controversial issues. A proposed literature review identified several studies that may be relevant to ocular surface disease and mechanisms of ocular protection against SARS-CoV-2.

Although only a fraction of patients with COVID-19 develop symptoms of conjunctivitis and only a fraction of patients test positive for polymerase chain reaction (PCR) on conjunctival scrapings, SARS- Further studies are needed to better characterize the presence of CoV-2 genetic material. in the tear fluid and determine whether the transmission of this virus occurred through the conjunctival mucosa and/or secretions.

Ophthalmologists are greatly concerned about the possibility of transmission of the new coronavirus through the surface of the eye. Thus, there is a high risk of transmission of SARS-CoV-2 to the ophthalmologist in examinations that require close physical contact with the patient. Therefore, the examination should be carried out by a doctor using personal protective equipment.

A review of the available literature can help clinicians identify ocular symptoms of COVID-19 infection and follow preventive measures.